Research
Shows MIG-99® Works*
Evaluated in 14 placebo-controlled scientific studies.
MIG-99® shows a favorable benefit-risk ratio.
|
MIG-99 |
Placebo |
| Subjects who experienced adverse events |
25.2% |
26.6% |
Mild, if any, side effects make MIG-99® easy to take. Across all scientific studies no serious adverse events were reported with MIG-99®. In one study, researchers documented that almost 100% of subjects completed the full course of treatment.
|
MIG-99 |
Placebo |
| Subjects who complied with full course of treatment |
93.5% |
92.6% |
MIG-99® delivers the same-strength product used in research. MIG-99 is prepared from feverfew using a proprietary supercritical carbon dioxide extraction and purification technology. Consumers receive the same 6.25 mg formulation used in research published in major scientific journals.